All News
STAT+: How RFK Jr. could impact addiction treatment
This week in health policy and politics news: What RFK Jr. could mean for addiction treatment and analyzing a bill to take on PBMs.
Read MoreDoc Confesses to Killing Wife, Police Say; Nurse Reprimanded for Cursing at Toddler
(MedPage Today) -- Orlando-area physician Thomas Wentzell, MD, was arrested and confessed to killing his wife, according to local police.
Read MoreWatch: ‘Going It Alone’ — A Conversation About Growing Old in America
Judith Graham, KFF Health News' "Navigating Aging" columnist, talks with older adults who live alone by choice or circumstance. They share what it means to thrive in later years.
Read MoreThe 7 Biggest Financial Enemies of Doctors
(MedPage Today) -- Success in personal finance and reaching financial freedom is not complicated. But that does not mean it is necessarily easy -- especially for doctors.
Read MoreSubcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
(MedPage Today) -- One of the most meaningful shifts in the cancer treatment landscape has been the move toward therapies that not only fight the disease, but also empower patients and healthcare pro
Read MoreFDA Issues Safety Alert on Liver Disease Drug
(MedPage Today) -- Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis (PBC) patients without cirrhosis, the FDA said in a safet
Read MoreProviders, You Are the Missing Piece: Your Patients With OUD Need You
(MedPage Today) -- As of 2023, more than 5 million people ages 12 or older in the U.S. have opioid use disorder (OUD).
Read MoreCanada’s rate of medically assisted deaths rises to record high
Roughly 96% of deaths by euthanasia in 2023 were for those with a terminal condition, as growth in overall cases slowsA growing share of deaths in Canada are from euthanasia, but the vast majority are
Read MoreHER2 Low and Ultralow Designations Open Door to Expansion of ADCs in Breast Cancer
(MedPage Today) -- The HER2-low and HER2-ultralow breast cancer subtype designations have led to a changed landscape in HER2-directed therapies, as well as a desire for more sensitive assays that may
Read MorePulled Myeloma Drug Improves Survival in Trial
(MedPage Today) -- SAN DIEGO -- A significant overall survival (OS) benefit with belantamab mafodotin (belantamab; Blenrep) in a phase III trial of relapsed or refractory multiple myeloma should sm
Read More